foxo4-dri peptide senolytic mouse study 2023 2024

foxo4-dri peptide senolytic mouse study 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound The costs and benefits of

Name: foxo4-dri peptide senolytic mouse study 2023 2024 The disordered p53 transactivation domain is the target of FOXO4 and the compound The costs and benefits of
Brand: lagence-mr.com
SKU: 6717436011
Price: 21.64 USD
Availability: InStock
Rating: 4.1224 (23 reviews)

The costs and benefits of senotherapeutics for human health The Lancet Healthy Longevity FOXO4 DRI induces keloid senescent fibroblast apoptosis by promoting nuclear exclusion of upregulated p53 serine 15 phosphorylation Communications Biology FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect foxo4 dri senolytic mouse 2023 2024 Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging: Cell Peptide targeting senescent cells restores Computational design of peptide targeting FOXO4. a, Domains of FOXO4 Download Scientific Diagram

SKU: 6717436011 · From lagence-mr.com

4.1

USD21.64 USD50.64

Pay in 4 interest-free payments of $5.41 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 14 - Sep 19

Description

7.3.2 Functional validation of epigenetic modifications 7.3.2.1 CRISPR-based epigenetic editing CRISPR/dCas9-mediated epigenetic editing provides powerful tools to reverse or confirm EED-induced DNA methylation changes (143)

Its short peptide structure allows researchers to work with clearly defined molecular compositions, improving experimental reproducibility and analytical accuracy